Company · CIK 0001631574 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Wave Life Sciences, Inc. · WVE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Adrian RawcliffeDirector | 12,700 | $5.29 | $67,183 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | $6.01 | $42,070 | 44,930 | −13.5% | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | $5.97 | $41,790 | 51,930 | — | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Ken TakanashiDirector | 3,864 | $6.01 | $23,223 | 20,079 | −16.1% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Tan Aik NaDirector | 432 | $6.01 | $2,596 | 24,968 | −1.70% | 10b5-1 |
| Mar 11, 2019 SForm 4 → | Mar 11, 7:18 pm EDT | Michael A. PanzaraFranchise Lead, Neurology | 7,000 | $48.00 | $336,000 | 45,388 | −13.4% | plan? |
| Mar 7, 2019 AForm 4 → | Mar 11, 7:19 pm EDT | Keith RegnanteChief Financial Officer | 13,500 | — | — | 29,186 | — | plan? |
| Mar 7, 2019 AForm 4 → | Mar 11, 7:18 pm EDT | Michael A. PanzaraFranchise Lead, Neurology | 15,000 | — | — | 52,388 | — | plan? |
| Mar 7, 2019 AForm 4 → | Mar 11, 7:17 pm EDT | Paul BolnoPresident and CEO, Director | 60,000 | — | — | 331,209 | — | plan? |
| Mar 7, 2019 AForm 4 → | Mar 11, 7:14 pm EDT | Chris FrancisSee Remarks | 13,500 | — | — | 33,868 | — | plan? |
| Mar 7, 2019 AForm 4 → | Mar 11, 7:13 pm EDT | Chandra VargeeseSenior VP, Drug Discovery | 15,000 | — | — | 40,245 | — | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 7:54 pm EST | Keith RegnanteChief Financial Officer | 1,298 | $36.84 | $47,818 | 15,686 | −7.64% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 7:53 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 1,837 | $36.84 | $67,674 | 37,388 | −4.68% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 7:51 pm EST | Paul BolnoPresident and CEO, Director | 7,733 | $36.40 | $281,456 | 271,209 | −2.77% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 7:49 pm EST | Chandra VargeeseSenior VP, Drug Discovery | 2,055 | $36.84 | $75,706 | 25,245 | −7.53% | plan? |
| Feb 19, 2019 SForm 4 → | Feb 21, 7:47 pm EST | Chris FrancisSee Remarks | 1,709 | $36.84 | $62,959 | 20,368 | −7.74% | plan? |
| Jan 24, 2019 PForm 4 → | Jan 28, 4:33 pm EST | RA CAPITAL MANAGEMENT, LLC +1Director, 10% Owner | 263,158 | $38.00 | $10,000,004 | 7,775,207 | +3.50% | plan? |
| Nov 14, 2018 SForm 4 → | Nov 16, 5:15 pm EST | Gregory L. VerdineDirector | 15,000 | $38.86 | $582,849 | 60,039 | −20.0% | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 7:01 pm EDT | Chris FrancisSee Remarks | 11,575 | $56.00 | $648,200 | 22,077 | −34.4% | plan? |
| Sep 24, 2018 MForm 4 → | Sep 26, 7:01 pm EDT | Chris FrancisSee Remarks | 11,575 | $2.48 | $28,706 | 32,620 | — | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 6:59 pm EDT | Keith RegnanteChief Financial Officer | 29,500 | $55.00 | $1,622,500 | 16,984 | −63.5% | plan? |
| Sep 24, 2018 MForm 4 → | Sep 26, 6:59 pm EDT | Keith RegnanteChief Financial Officer | 29,500 | $20.89 | $616,255 | 46,484 | — | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 6:58 pm EDT | Chandra VargeeseSenior VP, Drug Discovery | 3,000 | $55.00 | $165,000 | 27,300 | −9.90% | plan? |
| Sep 24, 2018 MForm 4 → | Sep 26, 6:58 pm EDT | Chandra VargeeseSenior VP, Drug Discovery | 3,000 | $2.48 | $7,440 | 30,300 | — | plan? |
| Jul 9, 2018 SForm 4 → | Jul 11, 5:05 pm EDT | Chris FrancisSee Remarks | 24,496 | $37.27 | $913,054 | 22,077 | −52.6% | plan? |
| Jul 9, 2018 MForm 4 → | Jul 11, 5:05 pm EDT | Chris FrancisSee Remarks | 24,496 | $2.48 | $60,750 | 22,673 | — | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 6:29 pm EDT | Chris FrancisSee Remarks | 48,992 | $46.75 | $2,290,376 | 22,077 | −68.9% | plan? |
| May 30, 2018 MForm 4 → | Jun 1, 6:29 pm EDT | Chris FrancisSee Remarks | 48,992 | $2.48 | $121,500 | 46,573 | — | plan? |
| May 25, 2018 SForm 4 → | May 30, 9:18 pm EDT | Paul BolnoPresident and CEO, Director | 31,711 | $45.00 | $1,426,995 | 278,942 | −10.2% | plan? |
| May 25, 2018 MForm 4 → | May 30, 9:18 pm EDT | Paul BolnoPresident and CEO, Director | 31,711 | $2.48 | $78,643 | 299,192 | — | plan? |
| May 2, 2018 SForm 4 → | May 4, 8:04 pm EDT | Paul BolnoPresident and CEO, Director | 18,289 | $45.00 | $823,005 | 278,942 | −6.15% | plan? |
| May 2, 2018 MForm 4 → | May 4, 8:04 pm EDT | Paul BolnoPresident and CEO, Director | 18,289 | $2.48 | $45,357 | 297,231 | — | plan? |
| Feb 16, 2018 MForm 4 → | Feb 21, 7:19 pm EST | Chris FrancisSee Remarks | 20,916 | $2.48 | $51,872 | 33,581 | — | plan? |
| Feb 16, 2018 SForm 4 → | Feb 21, 7:19 pm EST | Chris FrancisSee Remarks | 21,639 | $55.40 | $1,198,760 | 22,077 | −49.5% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 21, 7:18 pm EST | Paul BolnoPresident and CEO, Director | 2,714 | $51.50 | $139,783 | 278,942 | −0.96% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 21, 7:17 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 511 | $52.10 | $26,623 | 39,225 | −1.29% | plan? |
| Feb 16, 2018 SForm 4 → | Feb 21, 7:16 pm EST | Keith RegnanteChief Financial Officer | 316 | $51.85 | $16,385 | 16,984 | −1.83% | plan? |
| Feb 15, 2018 SForm 4 → | Feb 20, 7:36 pm EST | Chandra VargeeseSee Remarks | 2,000 | $50.00 | $100,000 | 27,300 | −6.83% | plan? |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:36 pm EST | Chandra VargeeseSee Remarks | 2,000 | $2.48 | $4,960 | 29,300 | — | plan? |
| Feb 15, 2018 SForm 4 → | Feb 20, 7:34 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 18,750 | $50.00 | $937,500 | 39,736 | −32.1% | plan? |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:34 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 18,750 | $21.69 | $406,688 | 58,486 | — | plan? |
| Jan 23, 2018 SForm 4 → | Jan 25, 8:12 pm EST | Chandra VargeeseSee Remarks | 2,000 | $40.00 | $80,000 | 9,800 | −16.9% | plan? |
| Jan 23, 2018 AMForm 4 → | Jan 25, 8:12 pm EST | Chandra VargeeseSee Remarks | 19,500 | $2.48 | $4,960 | 27,300 | — | plan? |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:10 pm EST | Chris FrancisSee Remarks | 13,000 | — | — | 22,800 | — | plan? |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:06 pm EST | Keith RegnanteChief Financial Officer | 13,000 | — | — | 17,300 | — | plan? |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:05 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 17,500 | — | — | 39,736 | — | plan? |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:05 pm EST | Paul BolnoSee Remarks, Director | 54,500 | — | — | 281,656 | — | plan? |
| Nov 22, 2017 SForm 4 → | Nov 22, 9:28 pm EST | Chandra VargeeseSee Remarks | 1,500 | $35.00 | $52,500 | 0 | −100% | plan? |
| Nov 22, 2017 MForm 4 → | Nov 22, 9:28 pm EST | Chandra VargeeseSee Remarks | 1,500 | $2.48 | $3,720 | 1,500 | — | plan? |
| Nov 13, 2017 PForm 4 → | Nov 15, 4:35 pm EST | RA CAPITAL MANAGEMENT, LLC +1Director, 10% Owner | 423,398 | $23.34 | $9,881,550 | 7,512,049 | +5.97% | plan? |
| Sep 15, 2017 SForm 4 → | Sep 19, 9:09 pm EDT | Masaharu Tanaka +1Director, 10% Owner | 20,747 | $24.21 | $502,301 | 2,774,118 | −0.74% | plan? |
| Aug 7, 2017 GForm 5 → | Feb 14, 2018, 7:07 pm EST | Gregory L. VerdineDirector | 75,040 | — | — | 75,039 | — | plan? |
| Jul 12, 2017 SForm 4 → | Jul 13, 5:09 pm EDT | Michael A. PanzaraFranchise Lead, Neurology | 7,414 | $16.67 | $123,620 | 15,336 | −32.6% | plan? |
| Mar 29, 2017 SForm 4 → | Mar 31, 3:34 pm EDT | Masaharu Tanaka +1Director, 10% Owner | 433,825 | $24.91 | $10,806,581 | 2,794,865 | −13.4% | plan? |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:17 pm EST | Chandra VargeeseSee Remarks | 9,800 | — | — | 9,800 | — | plan? |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:14 pm EST | Keith RegnanteChief Financial Officer | 4,300 | — | — | 4,300 | — | plan? |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:14 pm EST | Paul BolnoSee Remarks, Director | 36,300 | — | — | 227,156 | — | plan? |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:13 pm EST | Michael A. PanzaraHead of Neurology Franchise | 6,900 | — | — | 29,650 | — | plan? |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:13 pm EST | Chris FrancisSee Remarks | 9,800 | — | — | 9,800 | — | plan? |
| Dec 7, 2016 MForm 4 → | Dec 9, 6:36 pm EST | Roberto GuercioliniSee Remarks | 24,000 | $2.47 | $59,280 | 4,000 | — | plan? |
| Aug 19, 2016 MForm 4 → | Aug 22, 4:12 pm EDT | Roberto GuercioliniSee Remarks | 5,000 | $2.47 | $12,350 | 5,000 | — | plan? |
| Jul 28, 2016 MForm 4 → | Jul 29, 4:41 pm EDT | Roberto GuercioliniSee Remarks | 5,000 | $2.47 | $12,350 | 5,000 | — | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 4:14 pm EDT | Michael A. PanzaraFranchise Lead, Neurology | 22,750 | — | — | 22,750 | — | plan? |
| Jun 15, 2016 SForm 4 → | Jun 17, 5:02 pm EDT | Gregory L. VerdineDirector | 52,000 | $16.70 | $868,400 | 150,079 | −25.7% | plan? |
| Nov 16, 2015 PForm 4 → | Nov 18, 7:55 pm EST | Ken Takanashi +1Director, 10% Owner | 125,000 | $16.00 | $2,000,000 | 1,984,130 | +6.72% | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 7:55 pm EST | Ken Takanashi +1Director, 10% Owner | 161,663 | — | — | 1,859,130 | — | plan? |
| Nov 16, 2015 PForm 4 → | Nov 18, 7:29 pm EST | Masaharu Tanaka +1Director, 10% Owner | 76,250 | $16.00 | $1,220,000 | 3,228,690 | +2.42% | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 7:29 pm EST | Masaharu Tanaka +1Director, 10% Owner | 161,663 | — | — | 3,152,440 | — | plan? |
| Nov 16, 2015 PForm 4 → | Nov 18, 5:30 pm EST | RA CAPITAL MANAGEMENT, LLC +2Director, 10% Owner | 1,875,000 | $16.00 | $30,000,000 | 7,088,651 | +36.0% | plan? |
| Nov 16, 2015 CForm 4 → | Nov 18, 5:30 pm EST | RA CAPITAL MANAGEMENT, LLC +2Director, 10% Owner | 1,172,060 | — | — | 5,213,651 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 MForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | — | — | 0 | — | 10b5-1 |
| Sep 24, 2018 MForm 4 → | Sep 26, 7:01 pm EDT | Chris FrancisSee Remarks | 11,575 | — | — | 40,997 | — | |
| Sep 24, 2018 MForm 4 → | Sep 26, 6:59 pm EDT | Keith RegnanteChief Financial Officer | 29,500 | — | — | 90,500 | — | |
| Sep 24, 2018 MForm 4 → | Sep 26, 6:58 pm EDT | Chandra VargeeseSenior VP, Drug Discovery | 3,000 | — | — | 149,542 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:10 pm EDT | Peter KolchinskyDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:10 pm EDT | Christian O HenryDirector | 9,000 | — | — | 9,000 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:09 pm EDT | Gregory L. VerdineDirector | 9,000 | — | — | 9,000 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:08 pm EDT | Ken TakanashiDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:05 pm EDT | Koji MiuraDirector | 9,000 | — | — | 9,000 | — | |
| Aug 13, 2018 AForm 4 → | Aug 15, 8:03 pm EDT | Adrian RawcliffeDirector | 9,000 | — | — | 9,000 | — | |
| Jul 9, 2018 MForm 4 → | Jul 11, 5:05 pm EDT | Chris FrancisSee Remarks | 24,496 | — | — | 52,572 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 6:29 pm EDT | Chris FrancisSee Remarks | 48,992 | — | — | 77,068 | — | |
| May 25, 2018 MForm 4 → | May 30, 9:18 pm EDT | Paul BolnoPresident and CEO, Director | 31,711 | — | — | 372,778 | — | |
| May 2, 2018 MForm 4 → | May 4, 8:04 pm EDT | Paul BolnoPresident and CEO, Director | 18,289 | — | — | 404,489 | — | |
| Feb 16, 2018 MForm 4 → | Feb 21, 7:19 pm EST | Chris FrancisSee Remarks | 20,916 | — | — | 126,060 | — | |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:36 pm EST | Chandra VargeeseSee Remarks | 2,000 | — | — | 152,542 | — | |
| Feb 15, 2018 MForm 4 → | Feb 20, 7:34 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 18,750 | — | — | 131,250 | — | |
| Jan 23, 2018 AMForm 4 → | Jan 25, 8:12 pm EST | Chandra VargeeseSee Remarks | 37,000 | — | — | 35,000 | — | |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:10 pm EST | Chris FrancisSee Remarks | 26,000 | — | — | 26,000 | — | |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:06 pm EST | Keith RegnanteChief Financial Officer | 26,000 | — | — | 26,000 | — | |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:05 pm EST | Michael A. PanzaraFranchise Lead, Neurology | 35,000 | — | — | 35,000 | — | |
| Jan 23, 2018 AForm 4 → | Jan 25, 8:05 pm EST | Paul BolnoSee Remarks, Director | 109,000 | — | — | 109,000 | — | |
| Nov 22, 2017 MForm 4 → | Nov 22, 9:28 pm EST | Chandra VargeeseSee Remarks | 1,500 | — | — | 156,542 | — | |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:21 pm EDT | Adrian RawcliffeDirector | 9,000 | — | — | 9,000 | — | late |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:20 pm EDT | Peter KolchinskyDirector, 10% Owner | 9,000 | — | — | 9,000 | — | late |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:19 pm EDT | Ken TakanashiDirector, 10% Owner | 9,000 | — | — | 9,000 | — | late |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:19 pm EDT | Gregory L. VerdineDirector | 9,000 | — | — | 9,000 | — | late |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:18 pm EDT | Christian O HenryDirector | 9,000 | — | — | 9,000 | — | late |
| Aug 10, 2017 AForm 4 → | Aug 17, 4:18 pm EDT | Koji MiuraDirector | 9,000 | — | — | 9,000 | — | late |
| Feb 1, 2017 AForm 4 → | Feb 1, 6:39 pm EST | Adrian RawcliffeDirector | 18,000 | — | — | 18,000 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:17 pm EST | Chandra VargeeseSee Remarks | 19,500 | — | — | 19,500 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:14 pm EST | Keith RegnanteChief Financial Officer | 8,600 | — | — | 8,600 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:14 pm EST | Paul BolnoSee Remarks, Director | 72,500 | — | — | 72,500 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:13 pm EST | Michael A. PanzaraHead of Neurology Franchise | 13,800 | — | — | 13,800 | — | |
| Jan 25, 2017 AForm 4 → | Jan 27, 6:13 pm EST | Chris FrancisSee Remarks | 19,500 | — | — | 19,500 | — | |
| Dec 7, 2016 MForm 4 → | Dec 9, 6:36 pm EST | Roberto GuercioliniSee Remarks | 24,000 | — | — | 8,629 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 6:24 pm EST | Ken TakanashiDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 6:23 pm EST | Peter KolchinskyDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 5:53 pm EST | Christian O HenryDirector | 18,000 | — | — | 18,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 5:46 pm EST | Masaharu TanakaDirector, 10% Owner | 9,000 | — | — | 9,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 5:41 pm EST | Gregory L. VerdineDirector | 9,000 | — | — | 9,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 5:40 pm EST | Koji MiuraDirector | 9,000 | — | — | 9,000 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 5:40 pm EST | Takeshi WadaDirector | 9,000 | — | — | 9,000 | — | |
| Aug 19, 2016 MForm 4 → | Aug 22, 4:12 pm EDT | Roberto GuercioliniSee Remarks | 5,000 | — | — | 98,617 | — | |
| Aug 16, 2016 AForm 4 → | Aug 17, 6:37 pm EDT | Keith RegnanteChief Financial Officer | 120,000 | — | — | 120,000 | — | |
| Jul 28, 2016 MForm 4 → | Jul 29, 4:41 pm EDT | Roberto GuercioliniSee Remarks | 5,000 | — | — | 103,617 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 4:14 pm EDT | Michael A. PanzaraFranchise Lead, Neurology | 150,000 | — | — | 150,000 | — | |
| Jun 16, 2016 AForm 4 → | Jun 17, 5:05 pm EDT | Roberto GuercioliniSee Remarks | 32,500 | — | — | 32,500 | — | |
| Jun 16, 2016 AForm 4 → | Jun 17, 5:04 pm EDT | Kyle MoranSee Remarks | 30,000 | — | — | 30,000 | — | |
| Jun 16, 2016 AForm 4 → | Jun 17, 5:02 pm EDT | Paul BolnoSee Remarks, Director | 236,400 | — | — | 236,400 | — | |
| Jun 16, 2016 AForm 4 → | Jun 17, 5:01 pm EDT | Chandra VargeeseSee Remarks | 49,600 | — | — | 49,600 | — | |
| Jun 16, 2016 AForm 4 → | Jun 17, 5:00 pm EDT | Chris FrancisSee Remarks | 37,100 | — | — | 37,100 | — | |
| Aug 14, 2015 CPForm 4 → | Nov 18, 7:55 pm EST | Ken Takanashi +1Director, 10% Owner | 323,326 | $12.37 | $1,999,771 | 0 | — | late |
| Aug 14, 2015 CPForm 4 → | Nov 18, 7:29 pm EST | Masaharu Tanaka +1Director, 10% Owner | 323,326 | $12.37 | $1,999,771 | 0 | — | late |
| Aug 14, 2015 CPForm 4 → | Nov 18, 5:30 pm EST | RA CAPITAL MANAGEMENT, LLC +2Director, 10% Owner | 2,344,120 | $12.37 | $14,498,382 | 0 | — | late |